These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

79 related articles for article (PubMed ID: 6575127)

  • 1. Spironolactone-digoxin interaction.
    Hsieh YY; Lin MS; Chen JH; Hsu KL; Wu TL; Su CT; Shu MY; Hsu JC; Hsu WS; Chen JS
    Taiwan Yi Xue Hui Za Zhi; 1983 Jan; 82(1):47-60. PubMed ID: 6575127
    [No Abstract]   [Full Text] [Related]  

  • 2. [Clinical study on the subtoxic full effective and maintenance dose of digoxin under the influence of spironolactone. Studies on the decompensated heart patient].
    Krämer KD; Ghabussi P; Hochrein H
    Arzneimittelforschung; 1973 Apr; 23(4):508-11. PubMed ID: 4740227
    [No Abstract]   [Full Text] [Related]  

  • 3. Spironolactone in patients with heart failure.
    Fernandez HM; Leipzig RM
    N Engl J Med; 2000 Jan; 342(2):132; author reply 133-4. PubMed ID: 10636750
    [No Abstract]   [Full Text] [Related]  

  • 4. [Heart failure therapy with digitalis and spironolactone--studies within the scope of preoperative treatment before lung resection].
    Daum S; Goerg R; Mack D; Wang D
    Prax Klin Pneumol; 1984 Sep; 38(9):406-11. PubMed ID: 6504840
    [No Abstract]   [Full Text] [Related]  

  • 5. Clinical studies on digoxin intoxication. I. Serum concentration of digoxin in the elderly and the effect of diuretics.
    Suzuki M; Ogawa K
    Jpn Heart J; 1980 May; 21(3):341-56. PubMed ID: 7401316
    [No Abstract]   [Full Text] [Related]  

  • 6. Update on digoxin therapy in congestive heart failure.
    Haji SA; Movahed A
    Am Fam Physician; 2000 Jul; 62(2):409-16. PubMed ID: 10929703
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Congestive heart failure treated by a combination of cyclovirobuxine D with digoxin].
    Yan M
    Zhong Xi Yi Jie He Za Zhi; 1990 Feb; 10(2):88-9, 69. PubMed ID: 2364468
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Effect of combined treatment of diltiazem and digoxin on serum digoxin concentration].
    Zhang JL; Wu HS; Li QL
    Zhonghua Nei Ke Za Zhi; 1990 Nov; 29(11):646-8, 701. PubMed ID: 2086003
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Long-term effects of digoxin and hydralazine in patients with chronic cardiac insufficiency].
    Corbalán R; Arriagada D; Rodríguez JA; Chamorro G; Meleda I; Casanegra P; Valenzuela P
    Rev Med Chil; 1985 Oct; 113(10):947-53. PubMed ID: 3837287
    [No Abstract]   [Full Text] [Related]  

  • 10. [The pharmacokinetics of digoxin during chronic spironolacton treatment (author's transl)].
    Masson JP; Bass O; Baur HR; Ohnhaus EE
    Klin Wochenschr; 1978 Nov; 56(21):1071-6. PubMed ID: 713428
    [No Abstract]   [Full Text] [Related]  

  • 11. Impact of SLCO4C1 Genotypes, Creatinine, and Spironolactone on Digoxin Population Pharmacokinetic Variables in Patients With Cardiac Insufficiency.
    Du P; Wang A; Ma Y; Jia A; Li Y; Li X
    Clin Ther; 2020 Sep; 42(9):1799-1810.e3. PubMed ID: 32798059
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Spironolactone for congestive heart failure.
    Lindbloom EJ; Koenig CJ
    J Fam Pract; 1999 Oct; 48(10):752. PubMed ID: 12224671
    [No Abstract]   [Full Text] [Related]  

  • 13. Changes in the plasma levels and basic pharmacokinetic parameters of digoxin used in combination with gentamicin, amiodarone and spironolactone.
    Krusteva E
    Folia Med (Plovdiv); 1992; 34(2):24-8. PubMed ID: 1339769
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cross-sectional study of heart failure therapy with angiotensin converting enzyme inhibitors and digoxin.
    Mahmood SA; Hussein GM; Hamza EA
    Saudi Med J; 2004 Aug; 25(8):1060-5. PubMed ID: 15322598
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Treatment of refractory forms of congestive heart failure].
    Martynov AA; Petrovskiĭ VI
    Ter Arkh; 1979; 51(11):30-3. PubMed ID: 524281
    [No Abstract]   [Full Text] [Related]  

  • 16. Lack of efficacy of low-dose spironolactone as adjunct treatment to conventional congestive heart failure treatment in dogs.
    Schuller S; Van Israël N; Vanbelle S; Clercx C; McEntee K
    J Vet Pharmacol Ther; 2011 Aug; 34(4):322-31. PubMed ID: 20950346
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Combined therapy of captopril and spironolactone for refractory congestive heart failure.
    Han YL; Tong M; Jing QM; Hu XL; Liu JQ
    Chin Med J (Engl); 1994 Sep; 107(9):688-92. PubMed ID: 7805462
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Interaction of spironolactone with ACE inhibitors or angiotensin receptor blockers: analysis of 44 cases.
    Wrenger E; Müller R; Moesenthin M; Welte T; Frölich JC; Neumann KH
    BMJ; 2003 Jul; 327(7407):147-9. PubMed ID: 12869459
    [No Abstract]   [Full Text] [Related]  

  • 19. [Cardiac therapy using -methyl digoxin].
    Rummel W; Niederländer K
    Munch Med Wochenschr; 1972 May; 114(19):930-2. PubMed ID: 4559200
    [No Abstract]   [Full Text] [Related]  

  • 20. Carvedilol accelerate elevation of serum potassium in chronic heart failure patients administered spironolactone plus furosemide and either enalapril maleate or candesartan cilexetil.
    Saito M; Nakayama D; Takada M; Hirooka K; Yasumura Y
    J Clin Pharm Ther; 2006 Dec; 31(6):535-40. PubMed ID: 17176359
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.